Executive Summary
This batch of 50 filings reveals a significant shift in activist and institutional activity, with a notable increase in passive-to-active conversions and large strategic stake accumulations. The most critical development is the Tether/Rumble filing, where Tether now holds a 50.3% controlling stake, signaling a major strategic move in the digital media space.
We also see a pattern of institutional investors fully exiting SPAC positions (Magnetar Financial exiting 7 SPACs), while other entities like BlueArc Capital and Grey Rock are building or maintaining large, controlling stakes. Insider activity is mixed: the CEO of Addex Therapeutics repriced options to a near-zero strike price, signaling deep insider alignment but also highlighting severe share price decline, while Lantheus is actively selling its Perspective Therapeutics stake. Period-over-period comparisons are limited in these filings, but the data shows a clear trend of large, strategic block acquisitions and a rotation away from passive SPAC exposure. The most actionable insights center on the Tether/Rumble control, the GeoPark/Gilinski transaction, and the VolitionRx activist campaign.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Schedule 13D · Schedule 13G
Tracking the trend? Catch up on the prior US Activist Hedge Fund Institutional SEC 13D 13G digest from September 03, 2026.
Investment Signals (11)
- Rumble Inc. (Tether) ↓ (BULLISH)▲
Tether increased stake to 50.3% via a Top-Up Exchange, acquiring 8.26M ND shares and warrants for 16.74M more. This gives Tether outright control, a massive bullish signal for Rumble's strategic direction and potential integration with Tether's crypto ecosystem.
- GeoPark Ltd (Gilinski) ↓ (BULLISH)▲
Colden/Gilinski will become controlling shareholder via the Miranda Transaction, exchanging a 95% stake in EAI for 42.1M-47.6M new GeoPark shares. Post-closing, they must launch a tender offer at $12.22/share (capped at $100M), creating a potential floor for the stock.
- VolitionRx Ltd (Lagoda) ↓ (BULLISH)▲
Lagoda converted from passive (13G) to active (13D) status, sending a letter to the board on Aug 17, 2026, recommending cuts in exec comp and opex. This activist campaign could unlock value, though they don't currently seek board seats.
- Addex Therapeutics (CEO) (MIXED)▲
CEO Dyer repriced all options from strikes as high as CHF 3.00 down to CHF 0.026, deepening economic alignment. However, this massive repricing also signals the stock's severe decline and potential dilution, making it a mixed signal.
- Perspective Therapeutics (Lantheus) (BEARISH)▲
Lantheus sold 236,826 shares between Aug 31-Sep 3, 2026, and is authorized to sell more. This is a clear bearish signal from a strategic investor reducing its 10% stake.
- Arbutus Biopharma (Whitefort Capital) (BEARISH)▲
Whitefort reverted from active (13D) to passive (13G) status, indicating they no longer seek to influence control. This could signal a lack of confidence in a near-term catalyst or a strategic shift.
- Granite Ridge Resources (Grey Rock) (NEUTRAL)▲
Grey Rock entities collectively own 39.2% of the company, a massive controlling stake. This provides stability and a long-term strategic partner, but also limits public float and potential for activist-driven change.
- BioForce Nanosciences (Nexus Capital) (BEARISH)▲
Nexus acquired 79.6% of the company for just $400,000, a near-total control acquisition at a minimal price. This is a highly dilutive event for minority shareholders and signals a potential reverse merger or shell transaction.
- Karyopharm Therapeutics (Millennium Mgmt) (BULLISH)▲
Millennium Management disclosed a 5.7% passive stake. This is a notable vote of confidence from a top-tier quant fund in a struggling biotech, potentially signaling a value play or upcoming catalyst.
- Galiano Gold (BlackRock) (BULLISH)▲
BlackRock disclosed an 8.1% stake, with its BGF World Gold Fund holding >5% individually. This is a strong endorsement from the world's largest asset manager in the gold mining space.
- PG&E Corp (PointState Capital) ↓ (BULLISH)▲
PointState Capital disclosed a 5.1% passive stake. This is a significant position in a large-cap utility, potentially signaling a view that PG&E's post-bankruptcy recovery is undervalued.
Risk Flags (9)
- Addex Therapeutics / Dilution Risk↓ [HIGH RISK]▼
CEO repriced options from CHF 3.00 to CHF 0.026, a 99%+ reduction. This highlights a catastrophic share price decline and massive potential dilution if options are exercised.
- BioForce Nanosciences / Control Risk↓ [HIGH RISK]▼
Nexus Capital acquired 79.6% for $400k, implying a near-zero valuation for minority shares. This is a classic shell-company setup, with high risk of a dilutive reverse merger or other value-destructive actions.
- Perspective Therapeutics / Selling Pressure↓ [HIGH RISK]▼
Lantheus, a strategic investor, is actively selling its 10% stake (236,826 shares sold in 3 days). Continued selling could pressure the stock.
- Magnetar Financial / SPAC Exit Pattern [MEDIUM RISK]▼
Magnetar exited positions in 7 SPACs (EQV Ventures, Mountain Lake, SIM Acquisition, Centurion, Tessl, Churchill Capital, Vine Hill, Lionheart, Blue Acquisition). This systematic liquidation signals a broad loss of confidence in the SPAC asset class.
- ▼
Karpus Management reduced its position to zero, exiting a SPAC. This adds to the pattern of institutional SPAC flight.
- Radiopharm Theranostics / Lantheus Stake↓ [MEDIUM RISK]▼
Lantheus filed a 13G (passive) after previously filing a 13D, indicating they no longer seek control. This could signal a cooling of the strategic partnership.
- VolitionRx / Activist Risk↓ [MEDIUM RISK]▼
Lagoda's letter recommending cost cuts could lead to a proxy fight or management shakeup, creating uncertainty.
- Gap Inc. / Fisher Distribution↓ [LOW RISK]▼
The Fisher family distributed ~6.8M shares from trusts and LPs, reducing their direct holdings. While ownership % stayed at 13%, the distribution could signal a desire to monetize or diversify.
- eToro / Spark Capital Sale↓ [LOW RISK]▼
Spark Capital sold 5,783 shares at $28.01 immediately after a distribution. While small, this is a direct sale by a venture investor, potentially signaling a lack of conviction.
Opportunities (9)
- GeoPark Ltd / Tender Offer Floor↓ (OPPORTUNITY)◆
Gilinski must launch a post-closing tender offer at $12.22/share (capped at $100M). This provides a potential price floor and a clear catalyst for the stock.
- Rumble Inc. / Tether Control↓ (OPPORTUNITY)◆
Tether's 50.3% control could lead to strategic integration with Tether's crypto ecosystem, potentially driving significant value. The warrants also provide a path to further upside.
- VolitionRx / Activist Catalyst↓ (OPPORTUNITY)◆
Lagoda's activist campaign targeting cost cuts could unlock value. The stock may be undervalued if management executes on the recommendations.
- Galiano Gold / BlackRock Endorsement↓ (OPPORTUNITY)◆
BlackRock's 8.1% stake, with a dedicated gold fund holding >5%, is a strong vote of confidence. Gold mining stocks are often undervalued relative to gold prices.
- PG&E Corp / Value Play↓ (OPPORTUNITY)◆
PointState's 5.1% passive stake in a large-cap utility signals a potential value opportunity as PG&E continues its post-bankruptcy recovery.
- Karyopharm Therapeutics / Millennium Stake↓ (OPPORTUNITY)◆
Millennium Management's 5.7% stake in a beaten-down biotech could signal a near-term catalyst or a deep value play.
- Miller Industries / Neuberger Berman↓ (OPPORTUNITY)◆
Neuberger Berman disclosed a 10.0% passive stake, a significant position in a small-cap industrial. This could signal unrecognized value.
- AMG Pantheon Infrastructure / BlueArc Stake↓ (OPPORTUNITY)◆
BlueArc acquired a 32.3% stake for $99.4M, converting from 13G to 13D. This is a massive vote of confidence in infrastructure assets.
- TCW Specialty Lending / First Trust Stake↓ (OPPORTUNITY)◆
First Trust disclosed an 11.19% passive stake, a significant position in a specialty lending company. This could signal attractive risk-adjusted yields.
Sector Themes (6)
- SPAC Exodus◆
Magnetar Financial and Karpus Management are systematically exiting SPAC positions, with 8 total SPAC exits in this batch. This reflects a broad loss of confidence in the SPAC asset class post-redemption wave and regulatory scrutiny.
- Strategic Block Building◆
Multiple filings show large, strategic block acquisitions (Tether/Rumble 50.3%, Nexus/BioForce 79.6%, BlueArc/AMG Pantheon 32.3%, Grey Rock/Granite Ridge 39.2%). This suggests a trend of strategic investors taking controlling or near-controlling stakes, often at distressed valuations.
- Passive-to-Active Conversions◆
Two filings (VolitionRx, AMG Pantheon) show a shift from passive (13G) to active (13D) status, indicating increased activist or strategic intent. This could signal a broader trend of investors becoming more hands-on.
- Institutional Rotation Out of Small-Cap Biotech◆
Whitefort Capital reverted from active to passive on Arbutus Biopharma, while Lantheus is selling Perspective Therapeutics. This suggests a rotation away from small-cap biotech, despite Millennium's new stake in Karyopharm.
- Insider Alignment Through Option Repricing◆
The Addex CEO's massive option repricing (CHF 3.00 to CHF 0.026) is a drastic measure to align management with shareholders, but also highlights severe stock price declines. This tactic may become more common in distressed companies.
- Concentrated Ownership in Energy/Infrastructure◆
Grey Rock's 39.2% stake in Granite Ridge and BlueArc's 32.3% stake in AMG Pantheon highlight a trend of concentrated, long-term ownership in energy and infrastructure assets, providing stability but limiting liquidity.
Watch List (8)
-
Watch for governmental approvals and the effectiveness of the Venezuelan production contract. The tender offer at $12.22 is a key catalyst. [Date: TBD]
-
Watch for any announcements regarding integration with Tether's ecosystem, potential board changes, or further share purchases. [Date: Ongoing]
-
Watch for Lagoda's next steps, including potential proxy fight or further board engagement. The Aug 17 letter is a starting point. [Date: Ongoing]
-
Monitor Lantheus's selling activity. If they continue to sell, it could put significant pressure on the stock. [Date: Ongoing]
-
Watch for any exercise of the repriced options, which would dilute existing shareholders. The CEO's next moves are critical. [Date: Ongoing]
-
Watch for any change in Whitefort's stance or a new catalyst that could re-activate their interest. The reversion to passive is a key signal. [Date: Ongoing]
- Magnetar Financial / Further SPAC Exits👁
Monitor for additional Magnetar filings showing exits from other SPACs, which would confirm the trend. [Date: Ongoing]
-
Watch for any announcement of a reverse merger or other corporate action following Nexus's 79.6% acquisition. [Date: High Priority]
Filing Analyses
(50)
04-09-2026
Tether Global Investments Fund, S.I.C.A.F., S.A. and its wholly owned subsidiary Tether Investments, S.A. de C.V., together with Giancarlo Devasini, filed Amendment No. 4 to their Schedule 13D, disclosing beneficial ownership of 261,485,350 shares of RUM Group Inc. (f/k/a Rumble Inc.) Class A Common Stock, representing 50.3% of the outstanding shares. The filing also details a Top-Up Exchange on September 2, 2026, where Tether acquired 8,256,155 ND Shares, triggering the issuance of Pre-Funded Warrants for 16,744,307 additional shares. The reporting persons have voting and dispositive power over all 261,485,350 shares.
- · The filing is Amendment No. 4 to the Schedule 13D originally filed on February 7, 2025.
- · Tether Global Investments Fund changed its name from Tether Holdings, S.A. de C.V. on February 4, 2025, and from Tether Holdings Ltd on June 4, 2024.
- · The Support Agreement provides for monthly purchases of ND Shares by the Issuer in exchange for Class A Common Stock or Pre-Funded Warrants, subject to a Voting Limitation.
- · No transactions in Class A Common Stock occurred in the past 60 days except the Top-Up Exchange.
- · The CFTC settled with Tether in October 2021 for $41 million over misleading statements about USDT backing.
- · The NYAG settled with Tether and Bitfinex in February 2021 for $18.5 million over fund transfer issues.
04-09-2026
Chen Xueyi filed a Schedule 13G with the SEC on September 4, 2026, disclosing beneficial ownership of 250,000 ordinary shares of New Century Logistics (BVI) Ltd (NCEW), representing 7.78% of the 3,214,538 shares outstanding as of August 26, 2026. The filing indicates passive investment intent under Rule 13d-1(c), with sole voting and dispositive power over all shares.
- · Filing made under Rule 13d-1(c) indicating passive investment intent, not for control purposes.
- · Chen Xueyi has sole voting power and sole dispositive power over all 250,000 shares.
- · Address of beneficial owner: 7-2, 70 Wannian Village, Yuzhong District, Chongqing, China.
04-09-2026
Vanguard Capital Management LLC filed a Schedule 13G with the SEC on September 4, 2026, disclosing beneficial ownership of 1,228,308 shares of Liberty Media Corp (FWONB) common stock, representing a 5.11% stake. The filing is a correction of a previously filed Schedule 13G to fix the issuer CIK, with no change in beneficial ownership reported.
- · The filing is made under Rule 13d-1(b) of the Securities Exchange Act of 1934.
- · Vanguard Capital Management LLC is based in Malvern, Pennsylvania.
- · The filing includes securities held by Vanguard funds and managed accounts over which Vanguard Capital Management exercises dispositive power.
- · No other person's interest in the reported securities exceeds 5%.
- · The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
04-09-2026
Neuberger Berman Group LLC filed a Schedule 13G/A with the SEC on September 4, 2026, disclosing beneficial ownership of 1,135,556 shares of Miller Industries Inc. (MLR) common stock, representing a 10.0% stake. The filing indicates that Neuberger Berman and its affiliates hold the shares in a fiduciary capacity for clients, with no economic interest in the securities, and disclaim beneficial ownership under Rule 13d-4. The filing is an amendment to a prior Schedule 13G and reflects a passive investment position, not intended to influence control of the company.
- · The filing is an amendment (Schedule 13G/A) to a prior Schedule 13G, filed under Rule 13d-1(b), indicating passive investment intent.
- · Neuberger Berman Group LLC and its affiliates disclaim beneficial ownership of the securities under Rule 13d-4, as they hold the shares in fiduciary capacities for clients with no economic interest.
- · No single client holds an interest of more than 5% of the issuer's shares.
- · The filing excludes shares that may be deemed beneficially owned by NB Alternatives Advisers LLC and other subsidiaries separated by an information barrier per SEC Release No. 34-39538.
- · The filing was signed by Brad Cetron, Managing Director of both Neuberger Berman Group LLC and Neuberger Berman Investment Advisers LLC.
04-09-2026
Neuberger Berman Group LLC filed an amended Schedule 13G/A with the SEC on September 4, 2026, reporting beneficial ownership of 569 shares of AMERISAFE Inc common stock, representing 0% of the company's outstanding shares. The filing is made under Rule 13d-1(b) and includes a disclaimer of beneficial ownership by Neuberger Berman entities, indicating the shares are held in fiduciary capacities. This is a routine disclosure with no change in control intent.
- · The filing is an amendment (13G/A) to a prior Schedule 13G, filed under Rule 13d-1(b).
- · The reporting entities disclaim beneficial ownership under Exchange Act Rule 13d-4.
- · The securities are held in various fiduciary capacities, and the filing is not an admission of beneficial ownership.
- · Securities held by NB Alternatives Advisers LLC and other subsidiaries separated by an information barrier are not reflected in this filing.
- · The filing certifies that the securities were acquired and held in the ordinary course of business and not to change or influence control of the issuer.
04-09-2026
Nexus Capital Investments, Inc. filed a Schedule 13D disclosing acquisition of 26,700,000 shares of BioForce Nanosciences Holdings, Inc. (BFNH) common stock, representing approximately 79.6% of outstanding shares, for a total purchase price of $400,000. The shares were acquired in a private transaction funded through operational working capital. The filing indicates that both BFNH and Nexus Capital reserve the right to pursue future mergers, asset sales, board changes, or capital structure changes, though no specific plans are currently in place.
- · The acquisition date was April 22, 2026, but the Schedule 13D was filed on September 4, 2026.
- · Nexus Capital Investments is a Wyoming corporation with its business address in Athens, GA.
- · No other person has the right to receive or power to direct dividends or proceeds from the sale of the shares.
- · No trades in BFNH common stock were effected by the reporting person during the past 60 days prior to the filing.
- · BFNH was formerly known as Silver River Ventures, Inc. (name changed December 2, 2004).
04-09-2026
BlackRock Portfolio Management LLC filed an amended Schedule 13G with the SEC on September 4, 2026, disclosing beneficial ownership of 21,062,752 common shares of Galiano Gold Inc., representing 8.1% of the outstanding shares. The filing indicates that BlackRock's interest is held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. Notably, one of its business units, BGF World Gold Fund, individually holds more than 5% of Galiano Gold's outstanding common stock.
- · The filing is an amendment to a prior Schedule 13G, indicating a change in ownership details.
- · BlackRock's ownership is reported under Rule 13d-1(b), confirming passive investment intent.
- · BGF World Gold Fund, a business unit of BlackRock, individually holds more than 5% of Galiano Gold's outstanding common stock.
- · The filing includes a power of attorney dated July 1, 2025, appointing multiple attorneys-in-fact for regulatory filings.
- · Galiano Gold Inc. was formerly known as Asanko Gold Inc. (name change effective March 11, 2013) and Keegan Resources Inc. (name change effective October 6, 2006).
04-09-2026
Karpus Management, Inc. filed an amended Schedule 13G disclosing beneficial ownership of 820,275 common shares of Pantages Capital Acquisition Corp (PGACU), representing 15.97% of the outstanding shares. The filing indicates Karpus holds the shares in the ordinary course of business for its managed accounts and disclaims any intent to change or influence control of the issuer.
- · Karpus Management, Inc. is a registered investment adviser under Section 203 of the Investment Advisers Act of 1940.
- · Karpus is controlled by City of London Investment Group plc (CLIG), listed on the London Stock Exchange.
- · Effective informational barriers exist between Karpus and CLIG, so beneficial ownership is not attributed between them.
- · Karpus disclaims any purpose of changing or influencing control of the issuer.
- · The filing is an amendment (Schedule 13G/A) to a prior Schedule 13G.
04-09-2026
Karpus Management, Inc. filed an amended Schedule 13G with the SEC on September 4, 2026, disclosing that it beneficially owns 0 shares of Inflection Point Acquisition Corp. V (IPEXU) as of August 31, 2026. The filing indicates Karpus has reduced its position to zero, having previously held shares in the blank-check company.
- · Karpus Management is a registered investment adviser under the Investment Advisers Act of 1940 and is controlled by City of London Investment Group plc, which is listed on the London Stock Exchange.
- · Effective informational barriers exist between Karpus and CLIG, so beneficial ownership is not attributed between them.
- · The shares were owned directly by accounts managed by Karpus, and the filing certifies the securities were acquired and held in the ordinary course of business, not to change or influence control of the issuer.
04-09-2026
CEO Timothy Mark Dyer filed Amendment No. 10 to his Schedule 13D on September 4, 2026, disclosing beneficial ownership of 19,165,714 shares (9.01%) of Addex Therapeutics Ltd. The filing follows a reduction of the strike price on all his outstanding share options from an initial CHF 0.13 to CHF 0.026 per share on September 2, 2026, effectively deepening his economic alignment with shareholders. While this signals insider confidence, the massive option repricing from exercise prices of up to CHF 3.00 down to CHF 0.026 also highlights the steep decline in Addex's share price and potential dilution concerns.
- · The strike price on all previously granted options was reduced to CHF 0.026 on September 2, 2026, from initial strike prices as high as CHF 3.00 and CHF 0.13.
- · A total of 7,008,033 shares acquired on November 27, 2023 via option exercise remain subject to trading restrictions (1,053,061 not freely tradable as of September 2, 2026).
- · The CEO disclaimed any present plans for extraordinary corporate transactions, asset sales, board changes, delisting, or other major structural actions.
- · Voting and dispositive power over all 19,165,714 shares is held solely by Timothy Mark Dyer.
04-09-2026
PointState Capital LP and related entities filed a Schedule 13G with the SEC on September 4, 2026, disclosing beneficial ownership of 112,703,834 shares of PG&E Corporation common stock, representing 5.1% of the outstanding shares. The filing is made under Rule 13d-1(c) and includes a joint filing agreement among SteelMill Master Fund LP, PointState Holdings LLC, PointState Capital LP, PointState Capital GP LLC, and Zachary J. Schreiber. The reporting persons certify that the securities were not acquired with the purpose of changing or influencing control of PG&E.
- · The Schedule 13G was filed pursuant to Rule 13d-1(c), indicating the filer is a passive investor.
- · The filing date is September 4, 2026, with the event date of August 28, 2026.
- · The reporting persons are jointly filing but not as a group under Rule 13d-1(k)(1).
- · The principal business address of the reporting persons is 9 West 57th Street, 37th Floor, New York, NY 10019.
- · The filing certifies that the securities were not acquired for the purpose of changing or influencing control of the issuer.
04-09-2026
John J. Fisher, executive vice chairman of Pisces Inc., filed an amended Schedule 13D with the SEC on September 4, 2026, disclosing beneficial ownership of 45,799,467 shares of Gap Inc. common stock, representing approximately 13.0% of outstanding shares as of August 21, 2026. The filing reflects a net decrease in Fisher's holdings due to a pro rata distribution of 4,003,636 shares by Delaware limited partnerships and a distribution of 2,785,634 shares by trusts on September 2, 2026. Fisher states he has no present plans to acquire or dispose of additional shares, though he may do so in the future.
- · Fisher's beneficial ownership includes shares held through various structures: trusts, limited partnerships, community property, and proxies.
- · The filing is an amendment to a Schedule 13D originally filed in 2017, with multiple prior amendments.
- · Fisher has no present plans for extraordinary corporate transactions, changes in board or management, or other major actions listed in Item 4.
- · The distribution of shares on September 2, 2026, was made for no consideration.
04-09-2026
Robert J. Fisher, a director of Gap Inc. and managing director of Pisces Inc., filed an amended Schedule 13D reporting beneficial ownership of approximately 45,620,397 shares of Gap common stock, representing about 13.0% of the outstanding shares as of August 21, 2026. The filing reflects a pro rata distribution of 6,004,089 shares by Delaware limited partnerships and a distribution of 2,785,634 shares by trusts on September 2, 2026, but Fisher's overall ownership percentage remained unchanged at 13.0%. Fisher stated he has no current plans to acquire or dispose of additional shares, though he may do so in the future.
- · Robert J. Fisher's beneficial ownership includes shares held through trusts, limited partnerships, community property, and as executor of an estate.
- · The filing amends prior Schedule 13D filings dating back to January 3, 2017, with the most recent amendment before this one on June 5, 2026.
- · Fisher disclaims any present plans for extraordinary corporate transactions, changes in board or management, or other major actions listed in Item 4 of Schedule 13D.
- · As a non-employee director, Fisher is entitled to equity compensation; he holds 35,858 stock units and related dividend equivalent rights.
04-09-2026
Lantheus Holdings, Lantheus Medical Imaging, and Lantheus Alpha Therapy reported beneficial ownership of 11,440,513 shares of Perspective Therapeutics common stock, representing 10.0% of the outstanding shares as of September 3, 2026. However, Lantheus Alpha sold a combined 236,826 shares between August 31 and September 3, 2026, and the reporting persons stated that they are authorized to sell additional shares subject to certain market conditions.
- · The amendment adds Lantheus Medical Imaging, Inc. as an additional Reporting Person.
- · Lantheus Alpha Therapy, LLC is directly held by Lantheus Medical Imaging, Inc.; Lantheus Medical is wholly owned by Lantheus Holdings.
- · The Reporting Persons may have shared voting and dispositive power over the shares held by Lantheus Alpha.
- · The reported shares and ownership percentages were adjusted to reflect the June 14, 2024 1-for-10 reverse stock split.
- · Lantheus reported that it may sell shares through privately negotiated transactions, open-market transactions, block trades, registered offerings, underwritten transactions, accelerated transactions, derivative transactions, collars, prepaid forward transactions, swaps, exchange transactions, brokerage transactions, or other methods.
04-09-2026
BlueArc Capital Management, LLC and related entities filed a Schedule 13D with the SEC on September 4, 2026, disclosing that their aggregate beneficial ownership in AMG Pantheon Infrastructure Fund, LLC exceeded 20% (32.3% per share class) following a $99.4 million acquisition of Class S units on September 1, 2026. The filing converts from a previous Schedule 13G and is for passive investment purposes, with no intent to change control or management of the issuer.
- · The filing was triggered because beneficial ownership exceeded 20%, requiring conversion from Schedule 13G to Schedule 13D.
- · The acquisition was funded by working capital and fund assets, including capital contributions from members.
- · The number of units acquired and purchase price per unit are estimates based on the Issuer's estimated net asset value per unit as of the acquisition date.
- · None of the Reporting Persons has been convicted in a criminal proceeding or been party to a civil proceeding involving securities laws in the last five years.
04-09-2026
First Light Asset Management, LLC and its managing member Mathew P. Arens filed an amended Schedule 13G with the SEC, disclosing beneficial ownership of 4,043,931 shares (11.78%) and 4,203,931 shares (12.25%) of NeuroPace Inc, respectively, as of August 31, 2026. The filing indicates that the shares were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.
- · The filing is an amendment to a previous Schedule 13G, indicating a change in beneficial ownership.
- · First Light Asset Management acts as an investment adviser to separately managed accounts and private funds.
- · Mathew P. Arens controls First Light Asset Management as its managing member and majority owner.
- · The filing is made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
- · The reporting persons certify that the securities were not acquired for the purpose of changing or influencing control of the issuer.
04-09-2026
Lantheus Holdings, Inc. and its affiliates filed a Schedule 13G with the SEC on September 4, 2026, disclosing beneficial ownership of 792,958,513 ordinary shares of Radiopharm Theranostics Ltd, representing 17.3% of the outstanding shares. This filing amends a prior Schedule 13D, as the Reporting Persons no longer beneficially own more than 20% of the outstanding shares and do not hold the securities with the purpose of changing or influencing control of the issuer.
- · The Reporting Persons previously filed a Schedule 13D on September 4, 2026, which this Schedule 13G amends.
- · The Options expire on October 31, 2027.
- · The Reporting Persons' address is 201 Burlington Road, South Building, Bedford, MA 01730.
- · Each Reporting Person is organized in Delaware, United States.
- · The filing is made under Rule 13d-1(c) and Rule 13d-1(k).
04-09-2026
Lantheus Holdings, Inc. and its subsidiaries (Lantheus Omega, LLC and Lantheus Medical Imaging, Inc.) filed a Schedule 13D disclosing aggregate beneficial ownership of 20.9% of Radiopharm Theranostics Ltd's ordinary shares as of July 27, 2026. The stake comprises 537,958,513 ordinary shares and options to purchase an additional 255,000,000 shares, acquired through three private placements between August 2024 and December 2025 for a total of $15.0 million USD. The investment is strategic, tied to a June 2024 purchase of two preclinical assets and co-development partnerships, with Lantheus authorized to sell shares subject to market conditions.
- · The Reporting Persons acquired the securities for strategic investment purposes, including the June 2024 purchase of two preclinical assets and co-development partnerships.
- · The August 2024 shares were subject to a lock-up and escrow through August 23, 2025.
- · The January 2025 placement replaced the August Subscription Options, which became null and void.
- · The Reporting Persons are authorized to sell their shares subject to market conditions, through various transaction types.
- · No transactions in Ordinary Shares were engaged in during the past 60 days by the Reporting Persons.
- · The source of funds for the acquisitions was general working capital and cash on hand.
04-09-2026
First Trust Capital Management L.P. and related entities disclosed a 11.19% beneficial ownership stake in TCW Specialty Lending LLC as of April 30, 2026, holding 2,303,549.96 common units. The filing is a routine Schedule 13G by an investment adviser, indicating passive investment intent with voting rights waived above 5%.
- · The Reporting Persons have waived voting rights above 5%.
- · FTCS and Sub GP do not own any Common Units for their own accounts; they are deemed beneficial owners due to control over FTCM.
- · No one individual controls FTCS or Sub GP.
- · The filing is made under Rule 13d-1(b), indicating passive investment intent.
04-09-2026
First Trust Capital Management L.P. and related entities filed a Schedule 13G/A disclosing aggregate beneficial ownership of 2,303,549.96 common units (11.19%) in TCW Specialty Lending LLC as of June 30, 2026. First Trust Alternative Opportunities Fund separately holds 1,919,566.96 units (9.32%). All reporting persons have waived voting rights above 4.99%. The filing is an amendment to a prior 13G and reflects no change in the nature of the holdings (passive investment).
- · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(b) indicating passive investment intent.
- · All reporting persons have contractually waived voting rights above 4.99% of the issuer's common units.
- · FTCS and Sub GP do not own any common units for their own accounts; they are deemed control persons of FTCM.
- · The issuer changed its name from 'TCW Direct Lending VIII Perpetual BDC LLC' to 'TCW Specialty Lending LLC' on May 2, 2026.
- · Principal business address of FTCM, FTCS, and Sub GP is 225 W. Wacker Drive, 21st Floor, Chicago, IL 60606.
04-09-2026
First Trust Capital Management L.P. and related entities filed a Schedule 13G/A with the SEC, disclosing a 14.59% beneficial ownership stake in BC Partners Lending Corp as of March 31, 2025. The filing was prompted solely by a change in the issuer's outstanding shares, not by any change in the number of shares held by the reporting persons. The group collectively owns 567,119.65 shares of common stock.
- · The filing is an amendment (13G/A) filed on September 4, 2026, with an effective date of change as of September 4, 2026.
- · The filing was triggered by a change in the number of outstanding shares of BC Partners Lending Corp, not by any change in the number of shares held by the reporting persons.
- · First Trust Capital Solutions L.P. and FTCS Sub GP LLC are control persons of First Trust Capital Management L.P. but do not own any shares for their own accounts.
- · The reporting persons certify that the securities were acquired and are held in the ordinary course of business, not with the purpose of changing or influencing control of the issuer.
04-09-2026
Magnetar Financial LLC and related entities filed a Schedule 13G/A with the SEC on September 4, 2026, disclosing that as of June 30, 2026, they held 0 shares of Presidio MidCo Inc. (formerly EQV Ventures Acquisition Corp.), representing 0% of outstanding shares. The filing is an amendment to a prior beneficial ownership report and confirms the reporting persons have completely exited their position in the company.
- · The filing is an amendment (Schedule 13G/A) to a prior beneficial ownership report.
- · The reporting persons include Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman.
- · The filing was made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
- · The issuer changed its name from EQV Ventures Acquisition Corp. to Presidio MidCo Inc. on April 24, 2024.
- · The filing includes a Joint Filing Agreement and a Limited Power of Attorney dated December 22, 2022.
04-09-2026
Spark Capital entities and director Santo Politi filed Amendment No. 4 to their Schedule 13D for eToro Group Ltd., reporting a pro rata distribution of 3,559,007 Class A shares from Spark Capital II LP and 23,280 shares from Spark Capital Founders' Fund II LP to Spark Management Partners II LLC and its limited partners on August 12, 2026. Following the distribution, Spark Capital Partners LLC acquired 5,783 shares and sold them the same day at a weighted average price of $28.01 for aggregate proceeds of $162,000. The filing indicates no change in the group's aggregate beneficial ownership percentage, which remains 0.0% based on 66,806,610 Class A shares outstanding as of April 15, 2026.
- · The filing is Amendment No. 4 to the original Schedule 13D filed on May 21, 2025.
- · The distribution was pro rata and without additional consideration.
- · After the distribution, Spark Capital Partners LLC became the record holder of 5,783 shares and sold them the same day.
- · The Reporting Persons' aggregate beneficial ownership percentage is reported as 0.0% based on 66,806,610 Class A shares outstanding.
04-09-2026
Lagoda Investment Management, L.P. and related parties filed a Schedule 13D with the SEC on September 4, 2026, disclosing beneficial ownership of 1,652,005 shares of VolitionRx Ltd (VNRX), representing approximately 7.4% of outstanding common stock. The filing indicates a shift from passive (13G) to active (13D) status, with Fatima Dickey having sent a letter to the board on August 17, 2026, expressing support for management but recommending reductions in executive compensation and operating expenses. The reporting persons do not currently intend to seek board representation but reserve the right to acquire or dispose of additional securities.
- · The Schedule 13D was filed pursuant to Rule 13d-1(e), indicating a change from passive (13G) to active (13D) status.
- · Fatima Dickey sent a letter to the board on August 17, 2026, recommending reductions in executive compensation and other operating expenses.
- · The reporting persons do not currently intend to seek representation on the board of directors.
- · The warrants include a 4.99% beneficial ownership limitation, which can be increased up to 9.99% with 61 days' notice.
- · No transactions in the common stock were reported during the 60 days preceding the filing date.
04-09-2026
Integrated Core Strategies (US) LLC, an affiliate of Millennium Management, disclosed a 5.7% beneficial ownership stake in Karyopharm Therapeutics Inc. as of August 31, 2026, holding 1,297,297 shares of common stock. The filing is a routine Schedule 13G, indicating passive investment intent without any aim to influence or change control of the company.
- · The filing is made under Rule 13d-1(c), confirming passive investment intent.
- · The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest.
- · A joint filing agreement was executed on September 3, 2026, among the reporting entities.
04-09-2026
This Schedule 13D/A amendment discloses that GREP GP III, LLC and affiliated Grey Rock entities collectively beneficially own 51,648,048 shares (39.2%) of Granite Ridge Resources, Inc. common stock as of the filing date. The filing also details individual holdings by Matthew Miller (7.4%), Thaddeus Darden (6.4%), and Eric Holley (0.13%), and clarifies that no member of the Grey Rock Investment Committee is deemed to control Fund III's shares under the 'rule of three.' The ownership reflects a significant, controlling stake, but the filing does not indicate any change in control or new strategic actions.
- · The filing is Amendment No. 6 to Schedule 13D, amending and restating the original filed on September 1, 2023.
- · The filing parties include GREP GP III, LLC, Grey Rock Energy Partners GP III, L.P., GREP GP III Holdings, LLC, Grey Rock Energy Partners GP III-A, L.P., Grey Rock Energy Fund III-A, LP, GREP Holdco III-A, LLC, Grey Rock Energy Partners GP III-B, L.P., Grey Rock Energy Fund III-B, LP, Grey Rock Energy Fund III-B Holdings, L.P., GREP Holdco III-B Holdings, LLC, Grey Rock Energy Fund II-C, LLC, Grey Rock Management Partners V, LLC, Matthew Miller, Thaddeus Darden, and Eric Holley.
- · The Grey Rock Investment Committee consists of Matthew Miller, Thaddeus Darden, and Eric Holley; under the 'rule of three,' no member is deemed to beneficially own Fund III's shares.
- · Grey Rock II-C was formed for former limited partners of Fund II following a distribution of shares.
- · The principal business of the filing parties is investing in oil and gas assets and securities of companies holding such assets.
04-09-2026
Capital Research Global Investors filed a Schedule 13G/A with the SEC on September 4, 2026, disclosing that as of August 31, 2026, it beneficially owns 0 shares of Patria Investments Ltd common stock, representing 0.0% of the 66,584,651 shares outstanding. This amendment indicates that Capital Research Global Investors has fully exited its position in Patria Investments, having previously held shares.
- · Filing date: September 4, 2026
- · Date of event triggering filing: August 31, 2026
- · Shares believed outstanding: 66,584,651
- · Capital Research Global Investors certifies the shares were acquired and held in ordinary course of business, not to influence control
04-09-2026
Colden Investments S.A. and Jaime Gilinski filed a Schedule 13D/A disclosing that on September 2, 2026, affiliate Panamerican Energy Holdings S.A. (PEH) agreed to sell 95% of Energy Assets International S.A. (EAI) to GeoPark in exchange for 42.1M to 47.6M newly issued GeoPark shares (the Miranda Transaction). Following closing, the Reporting Persons are expected to become GeoPark's controlling shareholder, with current beneficial ownership of 18,115,791 shares (27.9% of shares outstanding as of June 30, 2026). However, the transaction is subject to conditions including governmental approvals and the effectiveness of a Venezuelan production contract, and PEH must launch a post-closing tender offer at $12.22 per share (capped at $100M) for all outstanding shares.
- · The SPA includes a Governance Agreement granting PEH approval rights over certain corporate matters (e.g., equity issuances >5%, dividend policy changes, board size changes) as long as PEH owns at least 15% of outstanding shares.
- · PEH's board nomination rights scale with ownership: 1 seat at 7.5%, 2 at 15%, 3 at 28%, 4 at 40%, and at least 5 at 50%.
- · If PEH or affiliates later cross a 70% ownership threshold, they must commence a further tender offer at no less than the 30-day volume weighted average trading price.
- · The PIPE SPA (March 5, 2026) had Colden purchase 12,876,053 GeoPark shares prior to this transaction.
04-09-2026
Whitefort Capital Management, LP and its affiliates filed a Schedule 13G with the SEC on September 4, 2026, disclosing beneficial ownership of 15,794,261 common shares of Arbutus Biopharma Corp, representing approximately 8.0% of the outstanding shares. The filing indicates that the reporting persons' investment intent has changed from active (previously filed a Schedule 13D in May 2024) to passive, as they no longer hold the securities with the purpose of changing or influencing control of the issuer.
- · The reporting persons initially filed a Schedule 13G on September 11, 2023, then changed to a Schedule 13D on May 9, 2024 due to a change in investment intent, and have now reverted to a passive Schedule 13G filing.
- · The beneficial ownership percentage (8.0%) is based on 198,105,743 shares outstanding as reported in the issuer's tender offer statement on Schedule TO filed August 24, 2026.
- · Each reporting person disclaims beneficial ownership of securities not directly owned.
04-09-2026
This Amendment No. 1 to Schedule 13G corrects the allocation of Class B shares and Class B units between Walter Thomas McAndrew, Jr. and McAndrew Holdings, Ltd. for ERock, Inc. The correction does not change W.T. McAndrew's aggregate beneficial ownership of 22,587,118 shares (31.9%), but increases the reported ownership of McAndrew Holdings, McAndrew Holdings, LLC, and Jay Willis McAndrew to 16,540,099 shares each (25.6%). The filing is purely administrative and does not reflect any change in total ownership or market activity.
- · The amendment corrects allocation of Class B shares and Class B Units between W.T. McAndrew and McAndrew Holdings, originally filed on August 14, 2026.
- · W.T. McAndrew directly owns 50,550 Class A shares and holds 5,996,469 Class B shares and corresponding Class B Units.
- · McAndrew Holdings holds 16,540,099 Class B shares and corresponding Class B Units.
- · All Class B Units are exchangeable on a one-for-one basis into Class A shares within 60 days of the filing date.
- · The filing is made under Rule 13d-1(d) of the Securities Exchange Act of 1934.
04-09-2026
Inflection Point Fund I, LP and its affiliates disclosed beneficial ownership of 15,890,625 ordinary shares (7.0%) of Pasqal Holding SA (formerly Bleichroeder Acquisition 2 France) as of August 27, 2026. The holdings include shares, warrants, and convertible bonds, with voting and dispositive power vested in an investment committee. The filing is a routine Schedule 13G filing under Rule 13d-1(c) and does not indicate any change in control intent.
- · The filing is made under Rule 13d-1(c) (passive investor exemption).
- · Voting and dispositive power is vested in an investment committee of three members, including Michael Blitzer (a director of the issuer) and Kevin Shannon (who assisted with the business combination with Bleichroeder Acquisition Corp. II).
- · Under the 'rule of three,' none of the individual committee members is deemed a beneficial owner of the securities.
- · The issuer changed its name from Bleichroeder Acquisition 2 France to Pasqal Holding SA on March 11, 2026, and from Bleichroeder Acquisition France Merger Sub 2 on May 22, 2026.
04-09-2026
3i, LP and related parties (3i Management LLC, Maier J. Tarlow) filed an amended Schedule 13G, reverting from a Schedule 13D, after their investment intent changed away from influencing control of Valion Bio, Inc. (formerly Tivic Health Systems, Inc.). The group beneficially owns 132,671 shares of common stock (9.9% of 1,285,626 shares outstanding as of August 24, 2026), consisting of 90,252 shares directly held and 42,419 shares issuable upon exercise of warrants and conversion of a $16,253,147.10 senior secured convertible note and preferred stock, all subject to a 9.99% blocker. The filing reflects a passive investment stance.
- · The filing is an amendment to a Schedule 13D, reverting to a Schedule 13G under Rule 13d-1(c) and 13d-1(h) because the reporting persons no longer hold securities with the purpose of changing or influencing control.
- · The company underwent a 1-for-25 reverse stock split effective August 31, 2026, and all share amounts reflect that split.
- · Tumim Stone Capital, LLC holds zero shares of the issuer.
- · The beneficial ownership percentage is based on 1,285,626 shares outstanding as of August 24, 2026, as verified with the issuer.
04-09-2026
Magnetar Financial LLC and related entities filed a Schedule 13G/A with the SEC on September 4, 2026, disclosing that as of June 30, 2026, they held zero shares of Mountain Lake Acquisition Corp. common stock, representing 0% beneficial ownership. The filing is an amendment to a prior Schedule 13G and confirms the reporting persons have no current stake in the company.
- · The filing is an amendment to Schedule 13G, filed pursuant to Rule 13d-1(b).
- · Magnetar Financial LLC serves as investment adviser to the Magnetar Funds and exercises voting and investment power over shares held for those funds.
- · Magnetar Capital Partners LP is the sole member and parent holding company of Magnetar Financial; Supernova Management LLC is the general partner of Magnetar Capital Partners; David J. Snyderman is the administrative manager of Supernova Management.
- · The reporting persons' principal business address is 1603 Orrington Avenue, 13th Floor, Evanston, Illinois 60201.
- · The filing includes a Joint Filing Agreement dated September 4, 2026, and a Power of Attorney dated December 22, 2022.
04-09-2026
Ameriprise Financial, Inc. and its subsidiary Columbia Management Investment Advisers, LLC filed a Schedule 13G/A disclosing beneficial ownership of 1,696,584 shares of Universal Electronics Inc. common stock, representing 13.2% of the outstanding shares as of August 31, 2026. The filing is a routine passive investment disclosure under Rule 13d-1(b), indicating the shares were acquired and are held in the ordinary course of business without the purpose of changing or influencing control of the issuer.
- · The filing is an amendment (SC 13G/A) to a previously filed Schedule 13G.
- · Ameriprise Financial, Inc. is a Delaware corporation; Columbia Management Investment Advisers, LLC is a Minnesota limited liability company; Columbia Small Cap Value Discovery Fund is a Massachusetts business trust.
- · Neither Ameriprise Financial nor Columbia Management Investment Advisers directly owns any shares; they may be deemed to beneficially own shares through their advisory relationship with the Fund and other managed accounts.
- · No other person besides the reporting entities and the Fund is known to have the right to receive dividends or proceeds from the sale of the reported securities.
- · The Fund is the only entity that owns more than 5% of the class; no other managed account individually exceeds 5%.
- · The filing includes a Joint Filing Agreement (Exhibit II) among the reporting persons.
04-09-2026
Magnetar Financial LLC and related entities filed a Schedule 13G/A with the SEC on September 4, 2026, disclosing that as of June 30, 2026, they held 0 shares of SIM Acquisition Corp. I common stock, representing 0% of the outstanding shares. The filing is an amendment to a prior beneficial ownership report and includes a joint filing agreement and power of attorney among the reporting persons.
- · The filing is an amendment to Schedule 13G, filed pursuant to Rule 13d-1(b).
- · Magnetar Financial LLC serves as investment adviser to the Magnetar Funds and exercises voting and investment power over shares held for those funds.
- · Magnetar Capital Partners LP is the sole member and parent holding company of Magnetar Financial.
- · Supernova Management LLC is the general partner of Magnetar Capital Partners.
- · David J. Snyderman is the administrative manager of Supernova Management.
- · The reporting persons' principal business address is 1603 Orrington Avenue, 13th Floor, Evanston, Illinois 60201.
- · The filing certifies that the securities were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.
- · Exhibit 99.1 is a Joint Filing Agreement dated September 4, 2026.
- · Exhibit 99.2 is a Limited Power of Attorney dated December 22, 2022, appointing Michael Turro, Karl Wachter, and Hayley Stein as attorneys-in-fact for David J. Snyderman.
04-09-2026
Magnetar Financial LLC and related entities filed a Schedule 13G/A disclosing beneficial ownership of 855,000 shares of Teamshares Inc. (formerly Live Oak Acquisition Corp. V), representing approximately 1.61% of the 73,660,516 shares outstanding as of June 30, 2026. The filing is an amendment to a prior 13G and reflects no change in ownership percentage from the previous filing, indicating a flat position. The shares are held across multiple Magnetar funds, with Magnetar Financial LLC serving as investment adviser.
- · The filing is an amendment (Schedule 13G/A) filed on September 4, 2026, with a date of change as of June 30, 2026.
- · The shares are held across eight Magnetar funds, with the largest holdings in Constellation Master Fund (188,102 shares) and Lake Credit Fund (171,004 shares).
- · The reporting persons certify the shares were acquired in the ordinary course of business and not to change or influence control of the issuer.
- · The filing includes a Joint Filing Agreement and a Power of Attorney dated December 22, 2022.
04-09-2026
Magnetar Financial LLC and related entities filed an amended Schedule 13G with the SEC on September 4, 2026, disclosing that as of June 30, 2026, they held zero shares of Centurion Acquisition Corp. common stock, representing 0% of the outstanding shares. The filing indicates that the Magnetar group has completely exited its position in the blank-check company, with no beneficial ownership remaining.
- · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
- · The reporting persons include Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman.
- · The filing certifies that the securities were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.
- · A joint filing agreement and a limited power of attorney were included as exhibits.
04-09-2026
Magnetar Financial LLC and related entities filed an amended Schedule 13G with the SEC on September 4, 2026, reporting that as of June 30, 2026, they held 0 shares of Tessl Holdings, Inc. common stock, representing 0% of the outstanding shares. The filing indicates the Magnetar group has fully exited its position in the company.
- · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(b), indicating the Magnetar group is a passive investor.
- · The Magnetar group previously held shares but has now reduced its position to zero.
- · The filing includes a joint filing agreement and a power of attorney dated December 22, 2022.
04-09-2026
Magnetar Financial LLC and related entities filed an amended Schedule 13G with the SEC on September 4, 2026, disclosing that as of June 30, 2026, they held zero Class A ordinary shares in Churchill Capital Corp IX/Cayman. The filing indicates the reporting persons have completely exited their position in the SPAC, representing 0% of shares outstanding.
- · The filing is an amendment to Schedule 13G, filed under Rule 13d-1(b).
- · Magnetar Financial LLC serves as investment adviser to the Magnetar Funds and previously exercised voting and investment power over the shares.
- · The reporting persons include Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman.
- · The filing includes a Joint Filing Agreement dated September 4, 2026, and a Power of Attorney dated December 22, 2022.
- · The issuer's SEC file number is 005-94505 and its fiscal year ends December 31.
04-09-2026
Magnetar Financial LLC and related entities (Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman) filed an amended Schedule 13G with the SEC on September 4, 2026, disclosing that as of June 30, 2026, they held 0 shares of Odysseus (Cayman) Ltd (formerly Vine Hill Capital Investment Corp.) common stock, representing 0% of shares outstanding. The filing indicates the reporting persons have completely exited their position in the issuer.
- · The filing is an amendment (SC 13G/A) to a prior Schedule 13G.
- · The issuer changed its name from Vine Hill Capital Investment Corp. to Odysseus (Cayman) Ltd on May 31, 2024.
- · The reporting persons' business address is 1603 Orrington Avenue, 13th Floor, Evanston, IL 60201.
- · The filing certifies the securities were acquired and held in the ordinary course of business, not to change or influence control of the issuer.
04-09-2026
Magnetar Financial LLC and related entities filed an amended Schedule 13G with the SEC on September 4, 2026, disclosing that as of June 30, 2026, they held 0 shares of Lionheart Holdings (CUBWU) common stock, representing 0% of the outstanding shares. The filing indicates no change in beneficial ownership from the prior period, with the group reporting zero holdings across all reporting persons.
- · The filing is an amendment to Schedule 13G, filed under Rule 13d-1(b), indicating passive investment intent.
- · Magnetar Financial LLC serves as investment adviser to the Magnetar Funds, which held no shares as of the reporting date.
- · The reporting persons include Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman, all with zero beneficial ownership.
- · A joint filing agreement and power of attorney were included as exhibits.
04-09-2026
Magnetar Financial LLC and related entities filed a Schedule 13G/A with the SEC on September 4, 2026, disclosing that as of June 30, 2026, they held zero shares of Blue Acquisition Corp/Cayman (BACCU) common stock, representing 0% of shares outstanding. The filing is an amendment to a prior beneficial ownership report and confirms the reporting persons have completely exited their position in the blank-check company.
- · The filing is an amendment (Schedule 13G/A) to a prior beneficial ownership report.
- · The reporting persons include Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman.
- · The filing certifies that the securities were acquired and held in the ordinary course of business, not for changing or influencing control of the issuer.
- · A Joint Filing Agreement dated September 4, 2026, and a Power of Attorney dated December 22, 2022, were included as exhibits.
04-09-2026
Truist Financial Corp filed a Schedule 13G/A with the SEC on September 4, 2026, disclosing beneficial ownership of 59,687 shares of ALPS ETF Trust, representing an 8.84% stake. The filing indicates Truist holds these shares through its subsidiary Truist Advisory Services, Inc., a registered investment advisor, and certifies the shares were acquired in the ordinary course of business without intent to influence control.
- · The filing is an amendment (SCHEDULE 13G/A) to a previous 13G filing.
- · Truist Financial Corp is classified as a Parent Holding Company (HC) and an Investment Adviser (IA).
- · The shares are held in the ordinary course of business and not for changing or influencing control of the issuer.
- · The filing date is September 4, 2026, with an event date of August 31, 2026.
04-09-2026
Truist Financial Corp filed a Schedule 13G/A with the SEC on September 4, 2026, disclosing that it beneficially owns 0 shares of Themes ETF Trust as of August 31, 2026. The filing indicates that Truist, through its subsidiary Truist Advisory Services, Inc., holds no position in the issuer, representing a decrease from any prior holdings.
- · Truist Financial Corp is a North Carolina corporation; Truist Advisory Services, Inc. is a Delaware corporation.
- · The filing is made under Rule 13d-1(b) (passive investment exemption).
- · Truist certifies that the securities were acquired and held in the ordinary course of business, not to change or influence control of the issuer.
04-09-2026
Truist Financial Corp filed an amended Schedule 13G with the SEC, disclosing beneficial ownership of 62,987 shares of ALPS ETF Trust, representing 5.6% of the trust's outstanding shares. The filing, made under Rule 13d-1(b), indicates the shares are held in the ordinary course of business by Truist Advisory Services, Inc., an affiliated registered investment advisor, and not for the purpose of changing or influencing control of the issuer.
- · The filing is an amendment (13G/A) to a prior Schedule 13G.
- · Truist Financial Corp is a North Carolina corporation; Truist Advisory Services, Inc. is a Delaware corporation.
- · The filing was made under Rule 13d-1(b), indicating passive investment intent.
- · The beneficial ownership is held by Truist Advisory Services, Inc., an affiliated registered investment advisor.
- · The filing date is September 04, 2026, with the report date of August 31, 2026.
04-09-2026
American Century Investment Management, Inc. and its affiliates filed a Schedule 13G/A with the SEC on September 4, 2026, disclosing beneficial ownership of 943,128 shares of MarineMax, Inc. (HZO) common stock, representing a 4.3% stake as of August 31, 2026. The filing indicates the shares were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.
- · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
- · American Century Investment Management, Inc. is a registered investment adviser under Section 203 of the Investment Advisers Act of 1940 and a wholly-owned subsidiary of American Century Companies, Inc.
- · American Century Companies, Inc. is controlled by the Stowers Institute for Medical Research.
- · The filers certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of MarineMax.
04-09-2026
First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation filed a Schedule 13G/A disclosing aggregate beneficial ownership of 57,886 shares (12.86%) of FT Vest Emerging Markets Buffer ETF - June, a series of First Trust Exchange-Traded Fund VIII, as of August 31, 2026. The shares are held by unit investment trusts sponsored by First Trust Portfolios L.P., with no individual trust holding more than 3% of the issuer. The filers disclaim beneficial ownership and state the shares were acquired in the ordinary course of business, not to influence control.
- · The filing is an amendment (13G/A) to a prior Schedule 13G.
- · The shares are held by unit investment trusts sponsored by First Trust Portfolios L.P., with First Trust Advisors L.P. acting as portfolio supervisor.
- · No individual unit investment trust holds more than 3% of the issuer's shares.
- · The reporting persons do not have the power to vote the shares; voting is done by the trustee of the unit investment trusts.
- · The reporting persons disclaim beneficial ownership of the shares.
- · The filing is made pursuant to Rule 13d-1(b) and includes a joint filing agreement under Rule 13d-1(k)(1).
04-09-2026
First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation filed a Schedule 13G/A disclosing aggregate beneficial ownership of 2,136,206 shares (34.32%) of FT Vest U.S. Equity Moderate Buffer ETF - October, a series of First Trust Exchange-Traded Fund VIII, as of August 31, 2026. The filing is an amendment to a prior Schedule 13G and indicates that the reporting entities disclaim beneficial ownership of the shares, which are held primarily by unit investment trusts and other managed accounts. No change in ownership percentage or control intent is indicated.
- · The filing is an amendment (13G/A) to a prior Schedule 13G, indicating no change in the nature of the filing from the initial beneficial ownership report.
- · The reporting persons disclaim beneficial ownership of the shares, which are held by unit investment trusts and other managed accounts where they serve as sponsor, portfolio supervisor, or investment advisor.
- · No individual unit investment trust sponsored by First Trust Portfolios L.P. holds more than 3% of any registered investment company issuer's shares.
- · The shares are voted by the trustee of the unit investment trusts, not by the reporting persons, except under certain conditions per Rule 12d1-4.
04-09-2026
First Trust Portfolios L.P. and its affiliates filed a Schedule 13G/A with the SEC on September 4, 2026, disclosing beneficial ownership of 2,780,807 shares of VanEck Emerging Markets High Yield Bond ETF, representing 10.70% of the outstanding shares. The filing indicates that the shares are held primarily through unit investment trusts sponsored by First Trust Portfolios L.P., and the reporting entities disclaim beneficial ownership of the shares.
- · The filing is an amendment (SC 13G/A) to a previous Schedule 13G.
- · First Trust Portfolios L.P. acts as sponsor of certain unit investment trusts that hold shares of the issuer.
- · No individual unit investment trust sponsored by First Trust Portfolios L.P. holds more than 3% of any registered investment company issuer's shares.
- · The reporting entities do not have the power to vote the shares; voting is done by the trustee of the unit investment trusts.
- · The filing is made jointly by The Charger Corporation, First Trust Portfolios L.P., and First Trust Advisors L.P. pursuant to Rule 13d-1(k)(1).
Get daily alerts with 11 investment signals, 9 risk alerts, 9 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Activist Hedge Fund Institutional SEC 13D 13G
September 02, 2026
US Activist Hedge Fund Institutional SEC 13D 13G — September 02, 2026
September 01, 2026
US Activist Hedge Fund Institutional SEC 13D 13G — September 01, 2026
August 31, 2026
US Activist Hedge Fund Institutional SEC 13D 13G — August 31, 2026
August 28, 2026
US Activist Hedge Fund Institutional SEC 13D 13G — August 28, 2026
🇺🇸 More from United States
View all →September 07, 2026
Global High-Priority Regulatory Events — September 07, 2026
Global High-Priority Regulatory Events
September 05, 2026
Mega Contracts Monitor ($100M+) — September 05, 2026
Mega Contracts Monitor ($100M+)
September 05, 2026
Federal IT & Cybersecurity Contracts — September 05, 2026
Federal IT & Cybersecurity Contracts
September 05, 2026
Federal Professional Services Contracts — September 05, 2026
Federal Professional Services Contracts